HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R Bolli Selected Research

R Bolli Research Topics

Disease

7Infarction (Infarctions)
12/2005 - 11/2000
6Myocardial Infarction
04/2014 - 08/2000
6Ischemia
11/2001 - 11/2000
5Coronary Occlusion
07/2001 - 08/2000
3Myocardial Ischemia (Ischemic Heart Diseases)
07/2014 - 04/2001
3Cardiomegaly (Heart Hypertrophy)
12/2001 - 06/2000
3Myocardial Stunning (Stunned Myocardium)
09/2001 - 08/2000
2Heart Diseases (Heart Disease)
05/2009 - 09/2001
2Hypertrophy
12/2001 - 09/2001
2Heart Failure
12/2001 - 01/2001
2Reperfusion Injury
09/2001 - 04/2001
1Cicatrix (Scar)
12/2013
1Cardiomyopathies (Cardiomyopathy)
12/2005
1Acute Coronary Syndrome
01/2001
1Hypoxia (Hypoxemia)
01/2001
1Septic Shock (Toxic Shock Syndrome)
01/2001
1Headache (Headaches)
07/2000

Drug/Important Bio-Agent (IBA)

4Protein Kinase CIBA
12/2001 - 06/2000
3Purinergic P1 Receptors (Adenosine Receptor)IBA
09/2001 - 03/2001
3N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA
09/2001 - 03/2001
3N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA
08/2001 - 08/2000
3Nitric Oxide Synthase (NO Synthase)IBA
07/2001 - 11/2000
2Protein Isoforms (Isoforms)IBA
12/2001 - 06/2000
2Protein Kinase C-epsilonIBA
12/2001 - 06/2000
2EnzymesIBA
11/2001 - 08/2000
2Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2001 - 11/2000
2Adenosine (Adenocard)FDA LinkGeneric
11/2001 - 08/2001
2N 0861IBA
09/2001 - 03/2001
2Proteins (Proteins, Gene)FDA Link
07/2001 - 08/2000
2Tyrosine (L-Tyrosine)FDA Link
07/2001 - 11/2000
2Phosphotransferases (Kinase)IBA
07/2001 - 11/2000
25-hydroxydecanoic acidIBA
03/2001 - 11/2000
2Adenosine Triphosphate (ATP)IBA
03/2001 - 11/2000
2Nitroarginine (NG Nitro L Arginine)IBA
03/2001 - 11/2000
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2014
1Receptors for Activated C KinaseIBA
12/2001
1NexusIBA
12/2001
1Protein Kinase C betaIBA
12/2001
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
11/2001
1EndotoxinsIBA
11/2001
1Opioid Analgesics (Opioids)IBA
11/2001
1Peptides (Polypeptides)IBA
09/2001
1IsoenzymesIBA
09/2001
1NitratesIBA
08/2001
1Nitroglycerin (Dynamite)FDA LinkGeneric
08/2001
1Adenosine A1 ReceptorIBA
08/2001
1Adenosine A3 ReceptorIBA
08/2001
1alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA
07/2001
1AntibodiesIBA
07/2001
1PhosphotyrosineIBA
07/2001
1Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
04/2001
1Superoxide DismutaseIBA
04/2001
12- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA
03/2001
1PotassiumIBA
03/2001
1I-kappa B Proteins (I kappa B)IBA
01/2001
1Free RadicalsIBA
01/2001
1CytokinesIBA
01/2001
1NF-kappa B (NF-kB)IBA
01/2001
1LipopolysaccharidesIBA
01/2001
1chelerythrineIBA
11/2000
1triphenyltetrazoliumIBA
11/2000
1Glycine (Aminoacetic Acid)FDA LinkGeneric
11/2000
1Oxidants (Oxidizing Agents)IBA
11/2000
1Diazoxide (Hyperstat)FDA Link
11/2000
1CalciumIBA
11/2000
1AntioxidantsIBA
11/2000
1Nitric Oxide DonorsIBA
11/2000
1Tyrosine Kinase InhibitorsIBA
11/2000
1S-Nitroso-N-AcetylpenicillamineIBA
11/2000
1lavendustin AIBA
11/2000
1Messenger RNA (mRNA)IBA
08/2000
1Celecoxib (Celebrex)FDA Link
08/2000
1ProstaglandinsIBA
08/2000
1Ribonucleases (Ribonuclease)IBA
08/2000
1Intravenous Immunoglobulins (IVIG)FDA Link
07/2000
1Ventricular MyosinsIBA
06/2000

Therapy/Procedure

3Therapeutics
07/2014 - 12/2013
2Cell- and Tissue-Based Therapy (Cell Therapy)
05/2009 - 12/2005